Clifford A. Hudis, MD, FACP, FASCO, ASCO CEO, introduces a new digital platform focusing on the role of artificial intelligence (AI) in cancer care. This platform, ASCO AI in Oncology, is designed to empower members of the American Society of Clinical Oncology (ASCO) and all oncology professionals with knowledge and the tools needed to adapt to a rapidly changing clinical and research environment. ASCO AI in Oncology seeks to provide timely, accurate, and trustworthy guidance in what is a technological revolution, ultimately leading to greater research and improved care for our patients with cancer.
ASCO AI in Oncology is brought to you by Conexiant, publisher of The ASCO Post, in partnership with ASCO.